Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 May 23;8(5):498.
doi: 10.3390/cells8050498.

c-Cbl: An Important Regulator and a Target in Angiogenesis and Tumorigenesis

Chimera L Lyle  1 , Mostafa Belghasem  2 , Vipul C Chitalia  3   4
Affiliations
Review

c-Cbl: An Important Regulator and a Target in Angiogenesis and Tumorigenesis

Chimera L Lyle et al. Cells. .

Abstract

Casitas B lineage lymphoma (c-Cbl) is a multifunctional protein with a ubiquitin E3 ligase activity capable of degrading diverse sets of proteins. Although previous work had focused mainly on c-Cbl mutations in humans with hematological malignancies, recent emerging evidence suggests a critical role of c-Cbl in angiogenesis and human solid organ tumors. The combination of its unique structure, modular function, and ability to channelize cues from a rich network of signaling cascades, empowers c-Cbl to assume a central role in these disease models. This review consolidates the structural and functional insights based on recent studies that highlight c-Cbl as a target with tantalizing therapeutic potential in various models of angiogenesis and tumorigenesis.

Keywords: EGFR; FGFR; PDGFR; PLCγ1; RTK; VEGFR; Wnt signaling; angiogenesis; c-Cbl; c-Met; non-RTK; proteasomal degradation; tumors; ubiquitination; β–catenin.

PubMed Disclaimer

Conflict of interest statement

Authors report no conflict of interest.

Figures

Figure 1
Figure 1
The primary structure and domain organization of human Casitas b-lineage lymphoma family proteins. c-Cbl, Cbl-b and Cbl-c proteins contain highly conserved tyrosine kinase-binding (TKB), linker (L), RING finger (RF) and proline-rich (PR) domains. 4H: Four-helix bundle; EF: EF hand, SH2: Src-homology 2; UBA: Ubiquitin-associated domain.
Figure 2
Figure 2
c-Cbl regulates angiogenesis through Wnt signaling. Constitutively Wnt signaling is suppressed in endothelial cells. In absence of Wnt ligand, β-Catenin is downregulated by in a destruction complex in the cytosol consisting of Adenomatous Polyposis Coli (APC), where β-Catenin gets phosphorylated by GSK3β. This results in β-catenin ubiquitination and proteasomal degradation by E3 ligases such as c-Cbl and β-TrCP, etc. Wnt ligand activates Frz receptors, which dissociates the destruction complex, β-catenin undergoes nuclear translocation and activates the Wnt target genes such as IL-8 and VEGF-A to induce angiogenesis. Wnt activation results in phosphorylation of c-Cbl, its nuclear translocation, wherein it ubiquitinates nuclear β-catenin to switch-off the Wnt signaling and angiogenesis.
Figure 3
Figure 3
c-Cbl is an attractive therapeutic target for angiogenesis and tumorigenesis. In the endothelial cells of vessels supplying the tumor, Wnt activation results in secretion of pro-angiogenic cytokines IL-8 and VEGF-A that augment tumor-induced angiogenesis. In colon cancer epithelial cells, inactivating mutations in APC tumor suppressor stabilizes β-Catenin and allows its nuclear translocation. This event results in the transcription of pro-proliferative and pro-oncogenic genes such as Cylin D1 and c-Myc to augment oncogenic activity. c-Cbl, by ubiquitinating nuclear β-Catenin in endothelial cells and in colon cancer cells, suppresses the growth of blood vessles and tumors. In addition, c-Cbl suppresses these processes by downregulating other pathways such VEGF signaling (PLCγ1) and mitogenic signaling (RTK and non-RTKs).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Simons M., Ware J.A. Therapeutic angiogenesis in cardiovascular disease. Nat. Rev. Drug Discov. 2003;2:863. doi: 10.1038/nrd1226. - DOI - PubMed
    1. Abhinand C.S., Raju R., Soumya S.J., Arya P.S., Sudhakaran P.R. VEGF-A/VEGFR2 signaling network in endothelial cells relevant to angiogenesis. J. Cell Commun. Signal. 2016;10:347–354. doi: 10.1007/s12079-016-0352-8. - DOI - PMC - PubMed
    1. Cantatore F.P., Maruotti N., Corrado A., Ribatti D. Angiogenesis Dysregulation in the Pathogenesis of Systemic Sclerosis. Biomed. Res. Int. 2017;2017:5345673. doi: 10.1155/2017/5345673. - DOI - PMC - PubMed
    1. Devi L., Pothana L., Goel S. Dysregulation of angiogenesis-specific signalling in adult testis results in xenograft degeneration. Sci. Rep. 2017;7:2605. doi: 10.1038/s41598-017-02604-4. - DOI - PMC - PubMed
    1. Patan S. Vasculogenesis and angiogenesis. Cancer Treat. Res. 2004;117:3–32. - PubMed

Publication types

MeSH terms